Cargando…
A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
NADPH oxidase (Nox)-derived reactive oxygen species (ROS) are increasingly recognized as a key factor in inflammation and extracellular matrix accumulation in diabetic kidney disease. APX-115 (3-phenyl-1-(pyridin-2-yl)-4-propyl-1-5-hydroxypyrazol HCl) is a novel orally active pan-Nox inhibitor. The...
Autores principales: | Kwon, Guideock, Uddin, Md Jamal, Lee, Gayoung, Jiang, Songling, Cho, Ahreum, Lee, Jung Hwa, Lee, Sae Rom, Bae, Yun Soo, Moon, Sung Hwan, Lee, Soo Jin, Cha, Dae Ryong, Ha, Hunjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650335/ https://www.ncbi.nlm.nih.gov/pubmed/29088780 http://dx.doi.org/10.18632/oncotarget.18540 |
Ejemplares similares
-
Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db/db mice
por: Dorotea, Debra, et al.
Publicado: (2018) -
Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors
por: Lee, Sae Rom, et al.
Publicado: (2020) -
APX‑115A, a pan‑NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ‑induced diabetic rat model
por: Noh, Min Hye, et al.
Publicado: (2023) -
Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan
por: Hyeon, Jin Seong, et al.
Publicado: (2020) -
Immunological study of an attenuated Salmonella Typhimurium
expressing ApxIA, ApxIIA, ApxIIIA and OmpA of Actinobacillus
pleuropneumoniae in a mouse model
por: HUR, Jin, et al.
Publicado: (2015)